Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme--improvement over available therapy?
- PMID: 18212790
- DOI: 10.1038/ncpneuro0712
Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme--improvement over available therapy?
Comment on
-
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.J Clin Oncol. 2007 Oct 20;25(30):4722-9. doi: 10.1200/JCO.2007.12.2440. J Clin Oncol. 2007. PMID: 17947719 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources